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Summary and Key Points 
1. Colorectal cancer is a common cancer which may be largely 
preventable by screening. 
2. There are well defined genetic syndromes which result in a 
markedly increased risk of developing colon cancer. 
3. Colon cancer that has not spread to distant organs is usually 
treated primarily by surgical resection. 
4. Rectal cancer has a higher probability of relapsing locally than 
colon cancer, and so is often treated initially with a combination of 
chemotherapy, radiation, and surgery. 
5. Adjuvant chemotherapy may be given after resection of either 
colon or rectal cancer to lower the risk of cancer recurrence. 
6. Metastatic colorectal cancer is not currently curable. While 
chemotherapy can prolong life in patients with metastatic disease, 
the primary goal of treatment is palliation of symptoms. 
Introduction 
Colorectal cancer is one of the most common types of cancer to affect 
individuals in the United States. It is the third most frequently diagnosed 
cancer as well as the third leading cause of cancer death among men 
and women. There were 150,000 new cases and nearly 50,000 deaths 
from colorectal cancer in the year 2008. Fortunately, these numbers 
have been decreasing since the late 1990s, largely attributable to 
increased screening for colorectal cancer and the removal of 
precancerous polyps. 
 
 
 
Etiology 
Colon and rectal cancers develop from changes in the mucosa, the inner 
lining of the intestine, that occur over time. (Figure 1) This progression is 
referred to as the "adenoma to carcinoma" sequence, and is a result of 
alterations in the DNA of the colonocytes. This sequence can be affected 
by genetic mutations passed among families, the most common of which 
are the adenomatous polyposis coli (APC) gene and mismatch repair 
(MMR) gene mutations. APC gene mutations are responsible for Familial 
Adenomatous Polyposis (FAP) syndrome. Patients with FAP will acquire 
hundreds or thousands of colonic polyps by the age of 20 and have a 
near 100% chance of developing colorectal cancer, usually before the 
age of 40. MMR gene mutations are included in Hereditary Non-
Polyposis Colon Cancer (HNPCC) syndrome. A thorough family history 
is necessary to help determine if an individual is at risk for one of these 
familial conditions. 
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Figure 1. (H&E stain, 2x magnification). Transition from normal colonic mucosa 
(left) to invasive well- differentiated adenocarcinoma (right). University of 
Massachusetts Medical School. Department of Pathology. 
 
These inherited conditions, while important, only account for a small 
minority of colon cancers. This means that most patients who develop 
colorectal cancer will have no significant family history. These cancers 
develop from acquired DNA mutations due to environmental factors 
acting on the colonic mucosa. Other causative factors that have been 
implicated in colorectal carcinogenesis include a high fat, low fiber diet 
and chronic inflammatory conditions such as inflammatory bowel 
disease. 
Screening 
As almost all colorectal malignancies start out as precancerous polyps, 
they can be identified and removed at the time of screening colonoscopy. 
(watch 2.44 minute movie) Currently, screening of the general population 
for colon cancer is recommended beginning at age 50, though it should 
be done earlier for patients with risk factors or family history. For the 
general population, annual stool testing by fecal occult blood, fecal 
immunochemical test (FIT), stool DNA test (sDNA) and flexible 
sigmoidoscopy every 5 years, colonoscopy every 10 years, double-
contrast barium enema every 5 years* or CT colonography (virtual 
colonoscopy, Figure 2) every 5 years are recommended. If any of the 
other tests are positive, then colonoscopy should follow immediately. 
 
 
Figure 2. 3D images from a screening CT Colonography (virtual colonoscopy) 
demonstrate a 1.5 cm polyp in the proximal transverse colon. University 
Massachusetts Medical School. Department of Radiology. 
 
Adherence to these screening recommendations will contribute to 
continued decline in the incidence of colon cancer that has been 
observed over the last twenty five years. It is important that physicians 
and patients realize that screening will not eliminate colon cancer. 
Screened patients still develop invasive cancer, probably due to lesions 
missed at colonoscopy, incomplete resection of polyps or predisposition 
to cancer because of genetics, lifestyle or other factors.1 
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Pathology 
Cancers of the colon and rectum originate from the mucosa, the 
epithelial lining of the gastrointestinal tract. For this reason, these tumors 
are almost exclusively adenocarcinomas. (Figures 3a-c) There are rare 
reports of squamous cell carcinomas in the low rectum, though there is 
debate whether these are truly anal cancers arising in the transitional 
epithelium of the anal canal. Other tumor types such as lymphoma, 
carcinoid, gastrointestinal stromal tumor (GIST), and melanoma are less 
common in the colon and rectum and have different modalities of 
treatment. Though a full discussion of these tumors is outside the scope 
of this chapter, their presence highlights the importance of biopsy to 
obtain a tissue diagnosis when dealing with a newly discovered colon or 
rectal mass 
 
 
Figure 3a. Gross image of colon resection: Polypoid lesion of invasive 
adenocarcinoma (see next figure). University of Massachusetts Medical School. 
Department of Pathology. 
 
Figure 3b. (H&E stain, 2x magnification) Invasive adenocarcinoma, moderately 
differentiated. Note the intermingling of the malignant tumor and benign bowel 
wall tissue. University of Massachusetts Medical School. Department of 
Pathology. 
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Figure 3c. (H&E stain, 40x magnification) High power of the malignant cells. 
Note the necrotic cells within the glandular lumen (short arrows). There is often 
extensive necrosis associated with colonic adenocarcinomas. The nuclei show 
size variation, prominent nucleoli, crowding, loss of polarity and mitotic figures 
(long arrows). University of Massachusetts Medical School. Department of 
Pathology. 
 
Staging 
Staging of colorectal cancer is performed once the diagnosis is 
confirmed by tissue biopsy of the primary lesion. This staging protocol, 
often referred to as a metastatic workup, is slightly different for colon 
cancer than rectal cancer. In colon cancer the primary concern is 
identification of distant metastatic disease, as this may change the 
treatment plan in regards to surgical resection (Figures 4, 5 & 6). While 
distant metastases are also a worry in new rectal cancers, staging of 
these tumors also includes in depth evaluation of the primary lesion 
given the concern for local invasion (Figure 7). 
 
 
Figure 4. Sixty-one year-old male patient presenting with bowel obstruction. 
Axial plane (a) and coronal plane (b) images from a contrast-enhanced CT scan 
of the abdomen and pelvis, demonstrate an “apple core” lesion in the distal 
transverse colon causing bowel obstruction. Patient underwent left 
hemicolectomy that confirmed the diagnosis of transverse colon 
adenocarcinoma. Note the presence of extramural soft tissue nodule (a) 
suggestive of extraserosal extension. University of Massachusetts Medical 
School. Department of Radiology. 
 
 
Figure 5. Seventy-five year-old female patient with newly diagnosed colon 
cancer. Axial plane (a) and coronal plane (b) images from a contrast-enhanced 
CT scan of the abdomen and pelvis, demonstrate multiple liver lesions and 
bilateral pleural effusions. Ultrasound-guided biopsy of the liver lesions and 
diagnostic thoracentesis, confirmed the diagnosis of liver metastases and 
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malignant pleural effusions. University of Massachusetts Medical School. 
Department of Radiology. 
 
 
Figure 6. Sixty-nine year-old male patient with known metastatic colon cancer. 
Lung window image form a CT scan of the chest demonstrates multiple lung 
metastases in both lower lobes. University of Massachusetts Medical School. 
Department of Radiology. 
 
 
Figure 7. Eighty-six year-old female patient with newly diagnosed rectal cancer. 
Axial T2-weighted image through the rectum from a rectal cancer protocol MRI 
examination, demonstrates a 2.2 cm rectal cancer. A soft tissue nodule is seen 
extending beyond the muscular layer (dark signal) and is suggestive of 
extraserosal extension. A perirectal lymph node was also present. Rectal gel is 
used to distend the lumen for better visualization of rectal tumors. University of 
Massachusetts Medical School. Department of Radiology. 
 
For a new colon cancer, staging primarily includes a CT scan of the 
chest, abdomen and pelvis with oral and intravenous contrast (Figure 4.. 
This study allows evaluation of the mesenteric lymph nodes surrounding 
the primary tumors (which often are not visible if they are not enlarged) 
as well as the liver (Figure 5) and lungs (Figure 6), two common 
locations of metastasis from colonic adenocarcinoma. 
Patients will also have blood work drawn in the form of a complete blood 
count with platelets, blood chemistries, and carcinoembryonic antigen 
(CEA) level, which is a protein that is often elevated in colon cancer. This 
level does not affect initial treatment decisions, but is used as a baseline 
for comparison with levels drawn during post-treatment surveillance for 
recurrent or metastatic disease. 
Rectal cancers present a slightly greater challenge in regards to staging, 
as their confined location within the pelvis and proximity to other 
structures leads to greater consequences from local invasion. Rectal 
cancer staging includes all of the elements listed above for colonic 
malignancies along with further evaluation of the primary tumor. First, a 
rigid proctoscopy is necessary to determine the level of the tumor within 
the rectum, often measured as the distance from the anus. This location 
has implications in surgical planning and when considering preoperative 
treatment. 
Endorectal ultrasound (ERUS) is one test that is used to evaluate the 
depth of penetration of the cancer into or through the wall of the rectum. 
This study also allows visualization of the mesorectum, where the lymph 
nodes draining the rectum are located. ERUS requires an ultrasound 
probe to be placed in the rectum, which is often done at the same time 
as the rigid proctoscopy. 
Another newer modality being used to stage rectal cancers is magnetic 
resonance imaging (MRI.) Pelvic MRI is very sensitive in evaluating the 
lymph nodes of the mesorectum, and newer high resolution MRI 
protocols have provided excellent image quality of the primary tumor, 
allowing accurate determination of depth of invasion as well (Figure 7). 
MRI is particularly useful in patients who have a bulky tumor or rectal 
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stricture that does not allow successful performance of ERUS. 
Oftentimes these studies are used in combination to get the most 
accurate staging information for each patient. 
All of the information that is obtained during the staging workup is put 
together to develop the clinical stage of the cancer. This becomes the 
pathologic stage once the tumor has been resected and microscopically 
evaluated. 
Principles of Treatment 
The main principle of treatment for either colon or rectal cancer is 
complete removal of the tumor with negative margins whenever this is 
anatomically possible. When metastatic disease is present or a tumor is 
considered surgically unresectable, the focus of treatment shifts to 
limiting the progression of the cancer and palliating the patient's 
symptoms. 
In the absence of distant metastasis (stage IV disease) patients with 
colon cancer undergo surgical resection as the primary method of 
treatment (see movie clip Colorectal Cancer Surgery). The goal of 
surgery is to remove the primary tumor along with all associated lymph 
nodes. If the final pathology shows involvement of the lymph nodes by 
the cancer or deep invasion through the wall of the colon, patients will be 
offered adjuvant chemotherapy to reduce the chance of developing 
recurrence or metastatic cancer. Radiation therapy is only given in cases 
where an incomplete surgical resection is performed, indicated by 
positive margins on the surgical specimen or tumor fixation to a normal 
structure, such as abdominal wall. 
Patients with rectal cancer are often treated with combination, or 
multimodal treatment. While those with stage I cancers can often be 
cured with surgery alone, these unfortunately represent a minority of 
cases. For stage II and III cancers, patients are given preoperative or 
"neoadjuvant" chemotherapy and radiation treatment to limit local 
invasion and increase the likelihood that surgery will be successful. 
Depending on the location of the tumor, surgical resection may require a 
temporary or permanent stoma (colostomy or ileostomy), where the stool 
drains into a bag through the abdominal wall. Patients who receive 
chemotherapy and radiation preoperatively will then undergo 
chemotherapy postoperatively to reduce the chance of developing 
recurrence or metastatic cancer. 
Patients with stage IV colorectal cancer are those whose tumor have 
spread to other distant organs, or have grown so extensively that it 
invades other nearby organs. In these patients, the focus shifts to 
evaluating the site and extent of their metastasis. As mentioned earlier, 
the liver and lungs are common locations of metastatic deposits in 
colorectal cancer. In cases of isolated metastatic disease to one of these 
locations, it is possible to still proceed with surgery to affect a cure by 
removal of the colonic tumor and the metastatic implant. If a patient is 
likely to live long enough to suffer the consequences of tumor 
progression, surgery and/or radiotherapy (for rectal cancer) to attempt to 
achieve local control may be indicated. Widely metastatic disease is 
treated with palliative chemotherapy; radiation and surgery are reserved 
for treatment of complications and symptoms. 
Conclusions 
Cancers of the colon and rectum are quite common and can be cured if 
discovered and treated in their earliest stages. Most of these tumors can 
be prevented through the use of screening colonoscopy. A majority of 
cancers occur in individuals over age 50, though any patient presenting 
with symptoms suggestive of cancer should be thoroughly evaluated. 
With a multidisciplinary approach involving surgeons, oncologists, and 
radiation oncologists, even the most challenging patients can be treated 
with encouraging results and high chance of cure 
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Thought Questions 
1. Death from colorectal cancer can be prevented by screening 
programs. Further, screening by colonoscopy can lower the 
incidence of colon cancer. How do the results of colon cancer 
screening by colonoscopy differ from the results of breast cancer 
screening by mammography? 
 
Your answer: 
 
 
 
 
 
 
 
 
 
 
 
Expert Answer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. Inherited mutation of APC causes FAP; acquired mutation of APC in 
colonocytes is a very common early event in the development of 
sporadic colon cancers. How are mutations in APC and their effect 
on colorectal cancer similar to and different from the effects of 
mutations in BRCA1 and BRCA2 on breast cancer? 
 
Your answer: 
 
 
 
 
 
 
 
 
 
 
 
 
 
Expert Answer 
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3. Radiation therapy after complete (R0) resection of rectal cancer 
clearly lowers the risk of local relapse of the tumor. However, 
radiation therapy after complete resection of colon cancer does not 
affect local relapse risk. Why should there be a difference in the 
effectiveness of radiation between completely resected rectal and 
colon cancers? 
 
Your answer: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Expert Answer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4. What symptoms would uncontrolled colon cancer cause? 
 
Your answer: 
 
 
 
 
 
 
 
 
Expert Answer 
 
 
 
 
 
5. What symptoms would uncontrolled rectal cancer cause? 
 
Your answer: 
 
 
 
 
 
 
 
Expert Answer: 
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Glossary 
Colonocytes- Mature, non-dividing epithelial cells that form the colonic 
epithelium 
Colostomy- A portion of the large intestine is brought through the 
abdominal wall ending in an opening outside the body. Stool is pushed 
out into a special bag, which has to be fixed to the abdominal wall. 
Ileostomy- A portion of the ilium is brought through the abdominal wall 
ending in an opening outside the body. Liquid stool (since the water 
absorption function of the colon is lost) is pushed out into a special bag, 
which has to be fixed even more tightly to the abdominal wall. 
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